# LEXISCAN

NDC: 0469-6501
Generic name: regadenoson
Labeler / Manufacturer: Astellas Pharma US, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20080410

FDA application: NDA022161

## Active ingredients

- REGADENOSON: .08 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0469-6501"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0469-6501
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=057289f4-2e18-4c1e-bed4-6c1858e2ef16